Ugo Testa researcher
Testa, Ugo
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Testa, Ugo (1953- )
VIAF ID: 307347236 (Personal)
Permalink: http://viaf.org/viaf/307347236
Preferred Forms
-
200 _ 1
‡a
Testa
‡b
, Ugo
‡f
<1953- >
-
100 1 _
‡a
Testa, Ugo
-
100 1 _ ‡a Testa, Ugo
-
100 1 _
‡a
Testa, Ugo
-
100 1 _ ‡a Testa, Ugo ‡d (1953- )
-
100 0 _
‡a
Ugo Testa
‡c
researcher
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| Fattori angiogenetici nelle malattie cardiovascolari : realtà, problemi e futuri sviluppi / Gaetano Pannitteri, Ugo Testa |
|
| Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor |
|
| Inhibition of transferring binding and iron uptake of hematopoietic cell lines by phorbol esters. |
|
| Interferon regulatory factor-2 drives megakaryocytic differentiation |
|
| Interferons and the differentiation of Friend cells. |
|
| Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotype |
|
| Interleukin-6 serum levels in patients with gynecological tumors |
|
| The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines |
|
| Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias |
|
| K562 cells induced to differentiate by phorbol ester tumor promotors resist NK lysis |
|
| Long-term culture of human LAK cells |
|
| M4 and M5 acute myeloid leukaemias display a high sensitivity to Bortezomib-mediated apoptosis |
|
| Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha |
|
| Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation |
|
| Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells |
|
| MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias |
|
| MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation |
|
| miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development. |
|
| miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias. |
|
| miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. |
|
| A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes. |
|
| Modulation by growth factors of the expression of interleukin 3 and granulocyte-macrophage colony-stimulating factor receptor common chain beta c. |
|
| Natural killer cells carry the germ-line configuration of the T cell receptor δ chain gene and heterogeneously express six distinct δ transcripts |
|
| Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 |
|
| New genetic variants of glucose 6-phosphate dehydrogenase (G6PD) in Italy |
|
| The origin of human B and T cells from multipotent stem cells: a study of the Tn syndrome |
|
| Oxidative stress and hypoxia in normal and leukemic stem cells |
|
| Oxidative stress leads to a rapid alteration of transferrin receptor intravesicular trafficking. |
|
| Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. |
|
| PCR analysis of HIV-1 sequences and differential immunological features in seronegative and seropositive haemophiliacs |
|
| Phorbol esters inhibit the binding of low-density lipoproteins (LDL) to U-937 monocytelike cells |
|
| Platelet formation: a link between apoptosis and differentiation |
|
| PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis. |
|
| PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response |
|
| The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts |
|
| Podocalyxin is expressed in normal and leukemic monocytes. |
|
| Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome |
|
| Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients |
|
| Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis. |
|
| Proteins of iron metabolism |
|
| Pure human hematopoietic progenitors: direct inhibitory effect of transforming growth factors-beta 1 and -beta 2. |
|
| Reactivation of HbF synthesis in normal adult erythroid bursts by IL-3. |
|
| Regulation of Expression of Ferritin H-chain and Transferrin Receptor by Protoporphyrin IX |
|
| Relation of Various Plasma Growth Factor Levels in Patients With Stable Angina Pectoris and Total Occlusion of a Coronary Artery to the Degree of Coronary Collaterals |
|
| Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels |
|
| Role of Ets-1 in transcriptional regulation of transferrin receptor and erythroid differentiation |
|
| Role of IL-6 and CD23 in the resistance to growth arrest and apoptosis in LCL41 B lymphoma cells |
|
| Role of stem cell factor in the reactivation of human fetal hemoglobin. |
|
| Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines |
|
| SCF-mediated γ-globin gene expression in adult human erythroid cells is associated with KLF1, BCL11A and SOX6 down-regulation |
|
| A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells. |
|
| Specific modulation of surface receptors in J.774 macrophages by anchorage. |
|
| STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules |
|
| Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins |
|
| Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells |
|
| Supramaximal exercise mobilizes hematopoietic progenitors and reticulocytes in athletes |
|
| The synergistic effect of simultaneous addition of retinoic acid and vitamin D3 on the in-vitro differentiation of human promyelocytic leukemia cell lines could be efficiently transposed in vivo. |
|
| Target structure for natural killer cells: evidence against a unique role for transferrin receptor |
|
| Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy. |
|
| Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells. |
|
| Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. |
|
| Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARalpha fusion protein |
|
| TfR2 expression in human colon carcinomas |
|
| TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway |
|
| TGF beta induces a sustained c-fos expression associated with stimulation or inhibition of cell growth in EL2 or NIH 3T3 fibroblasts |
|
| Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitors. |
|
| Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation |
|
| Transferrin binding to K562 cell line. Effect of heme and sodium butyrate induction |
|
| Transferrin receptor 2 protein is not expressed in normal erythroid cells |
|
| Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes |
|
| Triterpenoids as new promising anticancer drugs. |
|
| Tumor necrosis factor alpha is a powerful apoptotic inducer in lymphoid leukemic cells expressing the P-170 glycoprotein |
|
| Vascular endothelial growth factors in cardiovascular medicine. |
|
| Zinc modulates c-Myc/Mad1 balance in human leukemia cells |
|
